The groundbreaking success of Sildenafil undeniably revolutionized the pharmaceutical landscape, but betting in companies primarily reliant on unbranded versions presents a uncertain picture. Although early profits were impressive, the cessation of patents and the rise of discounted alternatives have diminished market share. Thus, a thorough analys